Mineralys Therapeutics (MLYS) Short-term Investments (2022 - 2026)
Mineralys Therapeutics' Short-term Investments came in at $523.14 million for Q2 2026, up 134.5% from $223.13 million a year earlier but down 1.9% from the prior quarter.
Powered by 
Analysis
Mineralys Therapeutics (MLYS) Short-term Investments (2022 - 2026) Analysis & Trends
At the end of FY2025, Mineralys Therapeutics' Short-term Investments was $483.71 million, up 475.2% from FY2024.
- Short-term Investments carries a three-year compound annual growth rate of 178.4% (FY2022 to FY2025).
- Going back by year, Short-term Investments was $84.1 million in FY2024 (-55.1%), $187.26 million in FY2023 (+735.7%) and $22.41 million in FY2022.
- The five-year range for quarterly Short-term Investments is $22.41 million (Q4 2022) to $533.3 million (Q1 2026).
- Year-over-year, Short-term Investments has increased for four consecutive quarters, with growth averaging 105.4% over the last eight quarters.
- The fastest year-over-year change in Short-term Investments over five years came in Q4 2023 (growth of 735.7%), and the weakest in Q4 2024 (a decline of 55.1%).
- Business Quant data shows MLYS's Short-term Investments at $533.3 million (Q1 2026), $483.71 million (Q4 2025) and $376.03 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn |
| 10 | Mineralys Therapeutics | 1.90 Bn | -660.85 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 523.14 Mn |
| Mar 31, 2026 | 533.30 Mn |
| Dec 31, 2025 | 483.71 Mn |
| Sep 30, 2025 | 376.03 Mn |
| Jun 30, 2025 | 223.13 Mn |
| Mar 31, 2025 | 178.02 Mn |
| Dec 31, 2024 | 84.10 Mn |
| Sep 30, 2024 | 166.33 Mn |
| Jun 30, 2024 | 243.26 Mn |
| Mar 31, 2024 | 248.15 Mn |
| Dec 31, 2023 | 187.26 Mn |
| Sep 30, 2023 | 167.46 Mn |
| Jun 30, 2023 | 159.96 Mn |
| Mar 31, 2023 | 132.39 Mn |
| Dec 31, 2022 | 22.41 Mn |
API Access
Mineralys Therapeutics Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=MLYS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "MLYS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=MLYS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();